Browse by Person

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Item Type | Date | No Grouping
2012 | 2011 | 2010 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1992
Number of items: 46.

2012

Snijder, C.A., Kortenkamp, A., Steegers, E.A.P., Jaddoe, V.W.V., Hofman, A., Hass, U. and Burdorf, A. (2012) Intrauterine exposure to mild analgesics during pregnancy and the occurrence of cryptorchidism and hypospadia in the offspring: the Generation R Study. Human Reproduction, 27 (4). pp. 1191-1201. 10.1093/humrep/der474.

2011

Silva, E., Rajapakse, N., Scholze, M., Backhaus, T., Ermler, S. and Kortenkamp, A. (2011) Joint effects of heterogeneous estrogenic chemicals in the E-Screen - exploring the applicability of concentration addition. Toxicological Sciences . 10.1093/toxsci/kfr103.

Kortenkamp, A. (2011) Are cadmium and other heavy metal compounds acting as endocrine disrupters? Metal Ions in Life Sciences, 8 . pp. 305-317.

Modarai, M., Silva, E., Suter, A., Heinrich, M. and Kortenkamp, A. (2011) Safety of Herbal Medicinal Products: Echinacea and Selected Alkylamides do not Induce CYP3A4 mRNA Expression. Evidence-Based Complementary and Alternative Medicine, 2011 (213021.). 10.1093/ecam/nep174..

Modarai, M., Suter, A., Kortenkamp, A. and Heinrich, M. (2011) The interaction potential of herbal medicinal prodicts: a luminescence-based screening platform assessing effects on cytochrome P-450 and its use with Devil's Claw (Harpagophyti radix) preparations. Journal of Pharmacy and Pharmacology, 63 (3). pp. 429-438. 10.1111/j.2042-7158.2010.01235.x.

Orton, F., Rosivatz, E., Scholze, M. and Kortenkamp, A. (2011) Widely used pesticides with previously unknown endocrine activity revealed as in vitro antiandrogens. Environmental Health Perspectives, 119 (6). pp. 794-800. 10.1289/ehp.1002895.

2010

Evans, R.M., Rahte, S. and Kortenkamp, A. (2010) Inability to confirm estrogenicity of the heterocyclic amine PhIP in two in vitro assays. Toxicology in Vitro, 24 (6). pp. 1757-1763. 10.1016/j.tiv.2009.12.017 .

Ermler, S., Scholze, M. and Kortenkamp, A. (2010) The sensitivity of the MDA-kb2 cell in vitro assay in detecting anti-androgenic chemicals - identification of sources of variability and estimation of statistical power. Toxicology in Vitro, 24 (6). pp. 1845-1853. 10.1016/j.tiv.2010.05.007 .

Silva, E., Kabil, A. and Kortenkamp, A. (2010) Cross-talk between non-genomic and genomic signalling pathways--distinct effect profiles of environmental estrogens. Toxicology and Applied Pharmacology, 245 (2). pp. 160-170. 10.1016/j.taap.2010.02.015 .

Kortenkamp, A. and Faust, M. (2010) Combined exposures to anti-androgenic chemicals: steps towards cumulative risk assessment. International Journal Of Andrology, 33 (2). pp. 463-474. 10.1111/j.1365-2605.2009.01047.x.

Modarai, M., Yang, M., Suter, A., Kortenkamp, A. and Heinrich, M. (2010) Metabolomic profiling of liquid Echinacea medicinal products with in vitro inhibitory effects on cytochrome P450 3A4 (CYP3A4). Planta Medica, 76 (4). pp. 378-385. 10.1055/s-0029-1186152.

2008

Heinrich, M., Modarai, M. and Kortenkamp, A. (2008) Herbal extracts used for upper respiratory tract infections: are there clinically relevant interactions with the Cytochrome P450 enzyme system? Planta Medica, 74 (5). pp. 657-660. 10.1055/s-2008-1034292.

Kortenkamp, A. (2008) Breast cancer and environmental risk factors: an appraisal of the scientific evidence. Breast Cancer Research, 10 (Suppl 2). P45. 10.1186/bcr1929.

Modarai, M., Suter, A., Kortenkamp, A. and Heinrich, M. (2008) CYP3A4 inhibitory compounds from Echinacea extract (Echinaforce). Planta Medica, 74 (9). 10.1055/s-0028-1084478.

Kabil, A., Silva, E. and Kortenkamp, A. (2008) Estrogens and genomic instability in human breast cancer cells--involvement of Src/Raf/Erk signaling in micronucleus formation by estrogenic chemicals. Carcinogenesis, 29 (10). pp. 1862-1868. 10.1093/carcin/bgn138.

Kortenkamp, A. (2008) Low dose mixture effects of endocrine disrupters: implications for risk assessment and epidemiology. International Journal Of Andrology, 31 (2). pp. 233-240. 10.1111/j.1365-2605.2007.00862.x.

2007

Modarai, M., Gertsch, J., Suter, A., Heinrich, M. and Kortenkamp, A. (2007) Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content. Journal of Pharmacy and Pharmacology, 59 (4). pp. 567-573. 10.1211/jpp.59.4.0012.

Silva, E., Scholze, M. and Kortenkamp, A. (2007) Activity of xenoestrogens at nanomolar concentrations in the E-Screen assay. Environmental Health Perspectives, 115 Suppl 1 . pp. 91-97. 10.1289/ehp.9363.

Kortenkamp, A. (2007) Introduction: Endocrine Disruptors-Exposure Assessment, Novel End Points, and Low-Dose and Mixture Effects. Environmental Health Perspectives, 115 (S-1). p. 7. 10.1289/ehp.10517..

Kortenkamp, A., Faust, M., Scholze, M. and Backhaus, T. (2007) Low-level exposure to multiple chemicals: reason for human health concerns? Environmental Health Perspectives, 115 (Suppl 1). pp. 106-114. 10.1289/ehp.9358..

Scholze, M. and Kortenkamp, A. (2007) Statistical power considerations show the endocrine disruptor low-dose issue in a new light. Environmental Health Perspectives, 115 (Suppl 1). pp. 84-90. 10.1289/ehp.9364.

Kortenkamp, A. (2007) Ten years of mixing cocktails: a review of combination effects of endocrine-disrupting chemicals. Environmental Health Perspectives, 115 (Suppl 1). pp. 98-105. 10.1289/ehp.9357.

2006

Kortenkamp, A. (2006) Breast cancer, oestrogens and environmental pollutants: a re-evaluation from a mixture perspective. International Journal Of Andrology, 29 (1). pp. 193-198. 10.1111/j.1365-2605.2005.00613.x.

Silva, E., Lopez-Espinosa, M.J., Molina-Molina, J-M., Fernández, M., Olea, N. and Kortenkamp, A. (2006) Lack of activity of cadmium in in vitro estrogenicity assays. Toxicology and Applied Pharmacology, 216 (1). pp. 20-28. 10.1016/j.taap.2006.04.002.

2005

Rajapakse, N., Butterworth, M. and Kortenkamp, A. (2005) Detection of DNA strand breaks and oxidized DNA bases at the single-cell level resulting from exposure to estradiol and hydroxylated metabolites. Environmental and Molecular Mutagenesis, 45 (4). pp. 397-404. 10.1002/em.20104.

2004

Rajapakse, N., Silva, E., Scholze, M. and Kortenkamp, A. (2004) Deviation from additivity with estrogenic mixtures containing 4-nonylphenol and 4-tert-octylphenol detected in the E-SCREEN assay. Environmental Science & Technology, 38 (23). pp. 6343-6352. 10.1021/es049681e.

2003

Tang, S., Schlage, C., Kortenkamp, A., Gray, A., Gibbons, S. and Heinrich, M. (2003) Bioflavonoids with cytotoxic and immunomodulatory activity from Ohna macrocalyx. Planta Medica, 69 (3). pp. 247-253. 10.1055/s-2003-38478.

Tang, S., Bremner, P., Kortenkamp, A., Schlage, C., Gray, A.I., Gibbons, S. and Heinrich, M. (2003) Biflavonoids with Cytotoxic and Antibacterial Activity fromOchna macrocalyx. Planta Medica, 69 (3). pp. 247-253. 10.1055/s-2003-38478.

2002

Rajapakse, N., Silva, E. and Kortenkamp, A. (2002) Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action. Environmental Health Perspectives, 110 (9). pp. 917-921.

Silva, E., Rajapakse, N. and Kortenkamp, A. (2002) Something from "nothing"--eight weak estrogenic chemicals combined at concentrations below NOECs produce significant mixture effects. Environmental Science & Technology, 36 (8). pp. 1751-1756. 10.1021/es0101227.

2001

Rajapakse, N., Ong, D. and Kortenkamp, A. (2001) Defining the impact of weakly estrogenic chemicals on the action of steroidal estrogens. Toxicological Sciences, 60 (2). pp. 296-304. 10.1093/toxsci/60.2.296.

Payne, J., Scholze, M. and Kortenkamp, A. (2001) Mixtures of four organochlorines enhance human breast cancer cell proliferation. Environmental Health Perspectives, 109 (4). pp. 391-397.

2000

Payne, J, Jones, C, Lakhani, S and Kortenkamp, A. (2000) Improving the reproducibility of the MCF-7 cell proliferation assay for the detection of xenoestrogens. Science of the Total Environment, 248 (1). pp. 51-62. 10.1016/S0048-9697(99)00479-9.

Payne, J., Rajapakse, N., Wilkins, M. and Kortenkamp, A. (2000) Prediction and assessment of the effects of mixtures of four xenoestrogens. Environmental Health Perspectives, 108 (10). pp. 983-987.

Jones, C. and Kortenkamp, A. (2000) RAPD library fingerprinting of bacterial and human DNA: applications in mutation detection. Teratogenesis, Carcinogenesis, and Mutagenesis, 20 (2). pp. 49-63. 10.1002/(SICI)1520-6866(2000)20:2<49::AID-TCM1>3.0.CO;2-D.

1999

Kortenkamp, A. and Altenburger, R. (1999) Approaches to assessing combination effects of oestrogenic environmental pollutants. Science of the Total Environment, 233 (1-3). pp. 131-140. 10.1016/S0048-9697(99)00228-4.

Casadevall, M., da Cruz Fresco, P. and Kortenkamp, A. (1999) Chromium(VI)-mediated DNA damage: oxidative pathways resulting in the formation of DNA breaks and abasic sites. Chemico-Biological Interactions, 123 (2). pp. 117-132. 10.1016/S0009-2797(99)00128-3.

1998

Kortenkamp, A. and Altenburger, R. (1998) Synergisms with mixtures of xenoestrogens: a reevaluation using the method of isoboles. Science of the Total Environment, 221 (1). pp. 59-73. 10.1016/S0048-9697(98)00261-7.

1997

Kortenkamp, A., Jones, C. and Baker, J. (1997) Genotypic selection of mutated DNA sequences using mismatch cleavage analysis, a possible basis for novel mutation assays. Mutagenesis, 12 (5). pp. 335-338. 10.1093/mutage/12.5.335.

1996

Kortenkamp, A., Casadevall, M., Faux, S.P., Jenner, A., Shayer, R.O., Woodbridge, N. and O'Brien, P. (1996) A role for molecular oxygen in the formation of DNA damage during the reduction of the carcinogen chromium (VI) by glutathione. Archives of Biochemistry and Biophysics, 329 (2). pp. 199-207. 10.1006/abbi.1996.0209.

Kortenkamp, A. (1996) Pharmacokinetic modelling in chromium risk assessment. Human and Experimental Toxicology, 15 (7). pp. 601-602.

1995

da Cruz Fresco, P., Shacker, F. and Kortenkamp, A. (1995) The reductive conversion of chromium (VI) by ascorbate gives rise to apurinic/apyrimidinic sites in isolated DNA. Chemical Research in Toxicology, 8 (6). pp. 884-890. 10.1021/tx00048a009.

1994

da Cruz Fresco, P. and Kortenkamp, A. (1994) The formation of DNA cleaving species during the reduction of chromate by ascorbate. Carcinogenesis, 15 (9). pp. 1773-1778. 10.1093/carcin/15.9.1773 .

Casadevall, M. and Kortenkamp, A. (1994) The generation of apurinic/apyrimidinic sites in isolated DNA during the reduction of chromate by glutathione. Carcinogenesis, 15 (2). pp. 407-409. 10.1093/carcin/15.2.407.

Kortenkamp, A. and O'Brien, P. (1994) The generation of DNA single-strand breaks during the reduction of chromate by ascorbic acid and/or glutathione in vitro. Environmental Health Perspectives, 102 Suppl 3 . pp. 237-241.

1992

Kortenkamp, A., Curran, B. and O'Brien, P. (1992) Defining conditions for the efficient in vitro cross-linking of proteins to DNA by chromium(III) compounds. Carcinogenesis, 13 (2). pp. 307-308.

This list was generated on Thu Sep 18 22:45:23 2014 BST.